EXECUTIVE OFFICE

Henri Caplain

PRESIDENT AND HONOR PRESIDENTIndependent Senior Adviser

Virginie Esposito

VICE-PRESIDENTSanofi

Delphine Elmerich

TREASURERTool4patient

Anne-Frédérique Ghuysen

SECRETARYRetired

Yves Donazzolo

ASSISTANT TREASURER AND HONOR PRESIDENTEurofins/Optimed

Bernard Orlandini

ASSISTANT SECRETARYPhinC Development

Board members

Henri CaplainIndependent Senior adviser

Virginie EspositoSanofi

Delphine ElmerichTools4patient

Anne-Frédérique GhuysenRetired

Bernard Orlandini Phinc

Yves Donazzolo Eurofins/Optimed

Pierre-François ClotSanofi

Denis GossenIndependent Consultant

Lionel Hovespian Sanofi

Eric Legangneux Novartis

EVENTS

january, 2022

25jan17 h 00 min18 h 30 minFree Online Webinar: Multi-specific Monoclonal Antibodies

Event Details

REGISTRATION LINK :

Webinar (microsoft.com)

Intervenants

Pr Hervé Watier : Hervé Watier is Professor of Immunology at the Faculty of Medicine, Tours, France, and Head of the Laboratory of Immunology in the University Hospital of Tours. He started his medical studies in Lille and his scientific training at the Pasteur Institute of Lille in 1989-91 before completing his MD and PhD theses in Tours. Through pharmacogenetic approaches, he discovered the importance of FcγRIIIA-dependent mechanisms in the action of cytolytic monoclonal antibodies in humans in 2002 and he then specialised in the structure-function relationship studies of therapeutic antibodies. He is coordinating the laboratory of excellence (LabEx) “MAbImprove” since 2011 and a regional program dedicated to biopharmaceuticals since 2013.

Dr Thierry WURCH, Sr.Director – Global External Innovation – Ipsen Since March 20, Thierry is External Innovation lead in Oncology at IPSEN. Dr. Wurch completed a Ph.D. in Molecular and Cellular Biology at the University Louis Pasteur (Strasbourg, FR), followed by post-doctoral training at the University of Ghent (BE). Back to France in 1994, he raised a molecular biology laboratory at the Pierre FABRE Research Center in Castres (FR). In 2003, he moved to the Center for Immunology Pierre FABRE where he established a Molecular and Cellular Biology Department dedicated to molecular pharmacology and protein and antibody engineering. In 2011, Thierry went to SERVIER where he successively led the immunotherapy discovery research programs until end 2016 then joined the newly created External Research and Innovation group overseeing global scouting activities in Oncology. Thierry Wurch is member of the Editorial board of MABS Journal (Taylor & Francis), Distinguished Advisor of The Antibody Society, member of the Scientific advisory board of MabDesign and Chair of the IUPHAR-NC Antibody Committee. He is co-author of more than 90 publications.

Time

(Tuesday) 17 h 00 min - 18 h 30 min ECT

Location

ONLINE

Organizer

AFPT - Le Club Phase 1

Calendar GoogleCal